Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
Multiple studies implicate heterozygous GBA mutations as a major genetic risk factor for Parkinson's disease (PD); however, the frequency of mutations has never been examined in PD patients from the Irish population. We prospectively recruited 314 unrelated Irish PD patients (UK Brain Bank Crit...
Main Authors: | Diana A. Olszewska, Allan McCarthy, Alexandra I. Soto-Beasley, Ronald L. Walton, Brian Magennis, Russell L. McLaughlin, Orla Hardiman, Owen A. Ross, Tim Lynch |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00527/full |
Similar Items
-
Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
by: Eileen E. Moran, et al.
Published: (2021-02-01) -
Glucocerebrosidase and its relevance to Parkinson disease
by: Jenny Do, et al.
Published: (2019-08-01) -
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons
by: Emily M. Rocha, et al.
Published: (2015-10-01) -
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
by: Micol Avenali, et al.
Published: (2020-04-01) -
Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
by: Elisa Menozzi, et al.
Published: (2021-06-01)